Mark Lappe, Chief Executive Officer at Inhibrx, Inc. (INBX), sold 60 shares at $25.02 ($2K) on 2023-02-28, disclosed to the SEC on 2023-03-01.
Scheduled sale ($2k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| INBX | BUY | 2024-09-10 | $671K | — | Filing → |
| INBX | BUY | 2024-09-03 | $913K | — | Filing → |
| INBX | BUY | 2024-08-22 | $1.0M | — | Filing → |